ArticleCancer chemotherapy and pharmacology2022

PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma.

Reeder M Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.